Načítá se...
Complement-mediated events in Alzheimer’s Disease: Mechanisms and Potential Therapeutic Targets
An estimated 5.7 million Americans suffer from Alzheimer’s disease in the United States with no disease modifying treatments to prevent or treat cognitive deficits associated with the disease. GWAS studies suggest that an enhancement of clearance mechanisms and/or promotion of an anti-inflammatory r...
Uloženo v:
| Vydáno v: | J Immunol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6951444/ https://ncbi.nlm.nih.gov/pubmed/31907273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1901068 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|